Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

A low cost, skin-color-matching tool to detect hyperbilirubinemia.

Bhutani VK.

J Pediatr. 2019 Sep;212:243-244. doi: 10.1016/j.jpeds.2019.07.012. No abstract available.

PMID:
31439166
2.

Sixty years of phototherapy for neonatal jaundice - from serendipitous observation to standardized treatment and rescue for millions.

Hansen TWR, Maisels MJ, Ebbesen F, Vreman HJ, Stevenson DK, Wong RJ, Bhutani VK.

J Perinatol. 2019 Aug 16. doi: 10.1038/s41372-019-0439-1. [Epub ahead of print] Review.

PMID:
31420582
3.

Frequency-following response among neonates with progressive moderate hyperbilirubinemia.

Musacchia G, Hu J, Bhutani VK, Wong RJ, Tong ML, Han S, Blevins NH, Fitzgerald MB.

J Perinatol. 2019 Jul 1. doi: 10.1038/s41372-019-0421-y. [Epub ahead of print]

PMID:
31263204
4.

A multi-center evaluation of a device for measurement of bilirubin binding capacity in neonates: the effects of gestational age, Intralipid exposure and illness severity.

Schutzman DL, Bhutani VK, Castillo Cuadrado ME, Lamola AA, Frantz I, Obregon E, Wong RJ.

J Perinatol. 2019 Jun;39(6):883-888. doi: 10.1038/s41372-019-0365-2. Epub 2019 Mar 27.

PMID:
30918342
5.

The Neonatal Acute Bilirubin Encephalopathy Registry (NABER): Background, Aims, and Protocol.

Bahr TM, Christensen RD, Agarwal AM, George TI, Bhutani VK.

Neonatology. 2019;115(3):242-246. doi: 10.1159/000495518. Epub 2019 Jan 22.

PMID:
30669144
6.

Rhesus disease: a global prevention strategy.

Zipursky A, Bhutani VK, Odame I.

Lancet Child Adolesc Health. 2018 Jul;2(7):536-542. doi: 10.1016/S2352-4642(18)30071-3. Epub 2018 Apr 20.

PMID:
30169325
7.

Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units.

Bhatt DR, Kristensen-Cabrera AI, Lee HC, Weerasinghe S, Stevenson DK, Bhutani VK, Maisels MJ, Ramanathan R.

J Perinatol. 2018 Nov;38(11):1532-1535. doi: 10.1038/s41372-018-0154-3. Epub 2018 Aug 17.

PMID:
30120424
8.

Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India.

Arora NK, Nair MKC, Gulati S, Deshmukh V, Mohapatra A, Mishra D, Patel V, Pandey RM, Das BC, Divan G, Murthy GVS, Sharma TD, Sapra S, Aneja S, Juneja M, Reddy SK, Suman P, Mukherjee SB, Dasgupta R, Tudu P, Das MK, Bhutani VK, Durkin MS, Pinto-Martin J, Silberberg DH, Sagar R, Ahmed F, Babu N, Bavdekar S, Chandra V, Chaudhuri Z, Dada T, Dass R, Gourie-Devi M, Remadevi S, Gupta JC, Handa KK, Kalra V, Karande S, Konanki R, Kulkarni M, Kumar R, Maria A, Masoodi MA, Mehta M, Mohanty SK, Nair H, Natarajan P, Niswade AK, Prasad A, Rai SK, Russell PSS, Saxena R, Sharma S, Singh AK, Singh GB, Sumaraj L, Suresh S, Thakar A, Parthasarathy S, Vyas B, Panigrahi A, Saroch MK, Shukla R, Rao KVR, Silveira MP, Singh S, Vajaratkar V.

PLoS Med. 2018 Jul 24;15(7):e1002615. doi: 10.1371/journal.pmed.1002615. eCollection 2018 Jul.

9.

Bilirubin binding in jaundiced newborns: from bench to bedside?

Ahlfors CE, Bhutani VK, Wong RJ, Stevenson DK.

Pediatr Res. 2018 Oct;84(4):494-498. doi: 10.1038/s41390-018-0010-3. Epub 2018 Jul 2. Review.

PMID:
29967530
10.

Acute neonatal bilirubin encephalopathy in the State of Utah 2009-2018.

Christensen RD, Agarwal AM, George TI, Bhutani VK, Yaish HM.

Blood Cells Mol Dis. 2018 Sep;72:10-13. doi: 10.1016/j.bcmd.2018.05.002. Epub 2018 May 23.

PMID:
29880417
11.

Identification of risk for neonatal haemolysis.

Bhutani VK, Maisels MJ, Schutzman DL, Castillo Cuadrado ME, Aby JL, Bogen DL, Christensen RD, Watchko JF, Wong RJ, Stevenson DK.

Acta Paediatr. 2018 Aug;107(8):1350-1356. doi: 10.1111/apa.14316. Epub 2018 Apr 16.

PMID:
29532503
12.

Rh sensitization in Canada is not obsolete.

Baker JM, Campbell DM, Bhutani VK, Sgro M.

Paediatr Child Health. 2017 Jul;22(4):238-239. doi: 10.1093/pch/pxx076. Epub 2017 May 31. No abstract available.

13.

The Importance of Hemolysis and Its Clinical Detection in Neonates with Hyperbilirubinemia.

Wong RJ, Bhutani VK, Stevenson DK.

Curr Pediatr Rev. 2017;13(3):193-198. doi: 10.2174/1573396313666170807121444. Review.

PMID:
28782473
14.

Skin-to-skin contact after birth and the natural course of neurosteroid levels in healthy term newborns.

McCallie KR, Gaikwad NW, Castillo Cuadrado ME, Aleman M, Madigan JE, Stevenson DK, Bhutani VK.

J Perinatol. 2017 May;37(5):591-595. doi: 10.1038/jp.2016.268. Epub 2017 Jan 19.

15.

Risk profiles for haemolytic and nonhaemolytic neonatal jaundice.

Bhutani VK, Wong RJ.

Acta Paediatr. 2016 Dec;105(12):1387-1388. doi: 10.1111/apa.13605. No abstract available.

PMID:
27870210
16.

Extreme hyperbilirubinemia and rescue exchange transfusion in California from 2007 to 2012.

Bhutani VK, Meng NF, Knauer Y, Danielsen BH, Wong RJ, Stevenson DK, Gould JB.

J Perinatol. 2016 Oct;36(10):853-7. doi: 10.1038/jp.2016.106. Epub 2016 Jul 21.

PMID:
27442156
17.

Preterm Neonates: Beyond the Guidelines for Neonatal Hyperbilirubinemia.

Stevenson DK, Bhutani VK.

Clin Perinatol. 2016 Jun;43(2):xvii-xviii. doi: 10.1016/j.clp.2016.01.013. Epub 2016 Jan 29. No abstract available.

PMID:
27235216
18.

The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.

Kaplan M, Hammerman C, Bhutani VK.

Clin Perinatol. 2016 Jun;43(2):325-40. doi: 10.1016/j.clp.2016.01.008. Epub 2016 Feb 28. Review.

PMID:
27235211
19.

Hyperbilirubinemia in Preterm Neonates.

Bhutani VK, Wong RJ, Stevenson DK.

Clin Perinatol. 2016 Jun;43(2):215-32. doi: 10.1016/j.clp.2016.01.001. Epub 2016 Mar 23. Review.

PMID:
27235203
20.

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

J Perinatol. 2016 Jul;36(7):533-9. doi: 10.1038/jp.2016.22. Epub 2016 Mar 3.

PMID:
26938918
21.

Filtered sunlight noninferior to conventional phototherapy.

Bhutani VK.

J Pediatr. 2016 Mar;170:341-2. doi: 10.1016/j.jpeds.2015.12.054. No abstract available.

PMID:
26922768
22.

Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia.

Bhutani VK, Srinivas S, Castillo Cuadrado ME, Aby JL, Wong RJ, Stevenson DK.

Acta Paediatr. 2016 May;105(5):e189-94. doi: 10.1111/apa.13341. Epub 2016 Feb 29.

PMID:
26802319
23.

Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency.

Bhutani VK, Kaplan M, Glader B, Cotten M, Kleinert J, Pamula V.

Pediatrics. 2015 Nov;136(5):e1268-75. doi: 10.1542/peds.2015-2122. Epub 2015 Oct 12.

24.

Rhesus disease: a major public health problem.

Zipursky A, Bhutani VK.

Lancet. 2015 Aug 15;386(9994):651. doi: 10.1016/S0140-6736(15)61498-2. No abstract available.

PMID:
26334154
25.

Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.

Kaplan M, Hammerman C, Bhutani VK.

J Perinatol. 2015 Oct;35(10):779-84. doi: 10.1038/jp.2015.77. Epub 2015 Jul 16. Review.

PMID:
26181718
26.

Bilirubin production and hour-specific bilirubin levels.

Bhutani VK, Wong RJ, Vreman HJ, Stevenson DK; Jaundice Multinational Study Group.

J Perinatol. 2015 Sep;35(9):735-8. doi: 10.1038/jp.2015.32. Epub 2015 Apr 16.

PMID:
25880796
27.

Keeping babies warm: a non-inferiority trial of a conductive thermal mattress.

Bhat SR, Meng NF, Kumar K, Nagesh KN, Kawale A, Bhutani VK.

Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F309-12. doi: 10.1136/archdischild-2014-306269. Epub 2015 Mar 19.

PMID:
25791056
28.

Evaluation of a new end-tidal carbon monoxide monitor from the bench to the bedside.

Castillo Cuadrado ME, Bhutani VK, Aby JL, Vreman HJ, Wong RJ, Stevenson DK.

Acta Paediatr. 2015 Jun;104(6):e279-82. doi: 10.1111/apa.12938. Epub 2015 Mar 13. No abstract available.

PMID:
25640053
29.

Impact of Rhesus disease on the global problem of bilirubin-induced neurologic dysfunction.

Zipursky A, Bhutani VK.

Semin Fetal Neonatal Med. 2015 Feb;20(1):2-5. doi: 10.1016/j.siny.2014.12.001. Epub 2015 Jan 9. Review.

PMID:
25582277
30.

Bilirubin-induced neurologic dysfunction (BIND).

Bhutani VK, Wong R.

Semin Fetal Neonatal Med. 2015 Feb;20(1):1. doi: 10.1016/j.siny.2014.12.010. Epub 2015 Jan 7. No abstract available.

PMID:
25577656
31.

The clinical syndrome of bilirubin-induced neurologic dysfunction.

Bhutani VK, Johnson-Hamerman L.

Semin Fetal Neonatal Med. 2015 Feb;20(1):6-13. doi: 10.1016/j.siny.2014.12.008. Epub 2015 Jan 7. Review.

PMID:
25577653
32.

Neonatal bilirubin binding capacity discerns risk of neurological dysfunction.

Lamola AA, Bhutani VK, Du L, Castillo Cuadrado M, Chen L, Shen Z, Wong RJ, Stevenson DK.

Pediatr Res. 2015 Feb;77(2):334-9. doi: 10.1038/pr.2014.191. Epub 2014 Nov 24.

PMID:
25420178
33.

Apnea in acute bilirubin encephalopathy.

Amin SB, Bhutani VK, Watchko JF.

Semin Perinatol. 2014 Nov;38(7):407-11. doi: 10.1053/j.semperi.2014.08.003. Epub 2014 Sep 17. Review.

34.

INCLEN Diagnostic Tool for Neuromotor Impairments (INDT-NMI) for primary care physician: development and validation.

Gulati S, Aneja S, Juneja M, Mukherjee S, Deshmukh V, Silberberg D, Bhutani VK, Pinto JM, Durkin M, Tudu P, Pandey RM, Nair MK, Arora NK; INCLEN Study Group.

Indian Pediatr. 2014 Aug;51(8):613-9.

35.

INCLEN diagnostic tool for attention deficit hyperactivity disorder (INDT-ADHD): development and validation.

Mukherjee S, Aneja S, Russell PS, Gulati S, Deshmukh V, Sagar R, Silberberg D, Bhutani VK, Pinto JM, Durkin M, Pandey RM, Nair MK, Arora NK; INCLEN Study Group.

Indian Pediatr. 2014 Jun;51(6):457-62.

36.

INCLEN Diagnostic Tool for Autism Spectrum Disorder (INDT-ASD): development and validation.

Juneja M, Mishra D, Russell PS, Gulati S, Deshmukh V, Tudu P, Sagar R, Silberberg D, Bhutani VK, Pinto JM, Durkin M, Pandey RM, Nair MK, Arora NK; INCLEN Study Group.

Indian Pediatr. 2014 May;51(5):359-65.

37.

Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.

Arain YH, Bhutani VK.

Indian J Pediatr. 2014 Jun;81(6):599-607. doi: 10.1007/s12098-014-1410-y. Epub 2014 Apr 26. Review.

PMID:
24763814
38.

Multidisciplinary guidelines for the care of late preterm infants.

Bhutani VK.

J Perinatol. 2014 Jan;34(1):81. doi: 10.1038/jp.2013.126. No abstract available.

PMID:
24374869
39.

Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, Bell J, Mori R, Slusher TM, Fahmy N, Paul VK, Du L, Okolo AA, de Almeida MF, Olusanya BO, Kumar P, Cousens S, Lawn JE.

Pediatr Res. 2013 Dec;74 Suppl 1:86-100. doi: 10.1038/pr.2013.208. Review.

40.

Jaundice and kernicterus in the moderately preterm infant.

Wallenstein MB, Bhutani VK.

Clin Perinatol. 2013 Dec;40(4):679-88. doi: 10.1016/j.clp.2013.07.007. Epub 2013 Sep 20. Review.

PMID:
24182955
41.

Bilirubin neurotoxicity in preterm infants: risk and prevention.

Bhutani VK, Wong RJ.

J Clin Neonatol. 2013 Apr;2(2):61-9. doi: 10.4103/2249-4847.116402. Review.

42.

Phototherapy device effectiveness in Nigeria: irradiance assessment and potential for improvement.

Cline BK, Vreman HJ, Faber K, Lou H, Donaldson KM, Amuabunosi E, Ofovwe G, Bhutani VK, Olusanya BO, Slusher TM.

J Trop Pediatr. 2013 Aug;59(4):321-5. doi: 10.1093/tropej/fmt027. Epub 2013 May 10.

PMID:
23666953
43.

Bilirubin nomogram, a prediction tool or natural history profile?

Bhutani VK.

Indian Pediatr. 2013 Apr;50(4):365-6. No abstract available.

44.

The effect of hematocrit on the efficacy of phototherapy for neonatal jaundice.

Lamola AA, Bhutani VK, Wong RJ, Stevenson DK, McDonagh AF.

Pediatr Res. 2013 Jul;74(1):54-60. doi: 10.1038/pr.2013.67. Epub 2013 Apr 19.

PMID:
23604171
45.

Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK.

J Perinatol. 2013 Jul;33(7):499-504. doi: 10.1038/jp.2013.14. Epub 2013 Feb 21. Review.

PMID:
23429543
46.

Need remains for evidence-based reassurance for absence of bilirubin neurotoxicity with severe hyperbilirubinaemia.

Bhutani VK.

Evid Based Med. 2013 Oct;18(5):189-90. doi: 10.1136/eb-2012-101058. Epub 2013 Jan 19. No abstract available.

PMID:
23335271
47.

Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.

Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK; Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group.

J Pediatr. 2013 Mar;162(3):477-482.e1. doi: 10.1016/j.jpeds.2012.08.022. Epub 2012 Oct 5.

PMID:
23043681
48.

Late preterm births major cause of prematurity and adverse outcomes of neonatal hyperbilirubinemia.

Bhutani VK.

Indian Pediatr. 2012 Sep;49(9):704-5. No abstract available.

49.

An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.

Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK.

J Perinatol. 2012 Sep;32(9):660-4. doi: 10.1038/jp.2012.71. Epub 2012 Jun 7. Review.

PMID:
22678141
50.

Neonatal phototherapy: choice of device and outcome.

Bhutani VK, Wong RJ.

Acta Paediatr. 2012 May;101(5):441-3. doi: 10.1111/j.1651-2227.2012.02605.x. Epub 2012 Feb 11. No abstract available.

PMID:
22251098

Supplemental Content

Loading ...
Support Center